Cryoport, Inc. (NASDAQ: CYRX) reported a pair of insider transactions tied to President and CEO Jerrell Shelton on March 23, 2026, according to a Form 4 filing with the U.S. Securities and Exchange Commission.
That filing shows Shelton sold 2,894 shares of Cryoport common stock at $8.18 per share, generating proceeds of $23,672. The transaction was executed on March 23, 2026. The company’s shares are trading at $8.41 at the time of the report, corresponding to a market capitalization of $418 million.
On the same calendar day Shelton also exercised stock options tied to restricted stock vesting. He acquired 25,000 shares under those options at an exercise price of $1.87 per share, representing a total outlay of $46,750. The filing specifies that these options were connected to the vesting of restricted stock rights.
Earnings release and market reaction
Cryoport’s fourth-quarter 2025 results were also included in recent company updates. Revenue for the quarter was reported at $45.45 million, beating the consensus estimate of $42.93 million. That outperformance equates to a 5.87% positive surprise relative to the forecast.
Despite the revenue beat, Cryoport’s per-share profitability metrics missed expectations. The company posted earnings per share of -$0.27 versus the anticipated -$0.21, a shortfall that translates to a 28.57% miss compared with consensus. Following these results, the company’s stock declined.
Third-party view and valuation note
Analysis from InvestingPro is cited noting that the stock appears overvalued at the current trading level. The InvestingPro note also references eight additional ProTips available to subscribers.
Where this leaves investors
The SEC Form 4 documents the CEO’s sale and the contemporaneous option exercise, while the company’s earnings release provides the financial context that accompanied the market reaction. The information reported includes the exact share counts, transaction prices, exercise price, and the quarterly revenue and EPS figures.
These developments represent the latest publicly disclosed updates concerning Cryoport Inc.